Four Poems
Release time:
2020-08-14
Four Poems
The students of Class 6, Class 6, Jinhua First Grade Gathered happily
to bid farewell to the campus like yesterday, with a flick of a finger for 50 years.
Alma Mater is deeply affectionate and has a long relationship between teachers and students.
Zhongshan Park has few tourists and many flowers in Tianchang Lane.
is the avenue of teachers and friends, such as cutting and learning the true biography.
After studying farming at the top of the mountain, he jumped into the pavilion and made bold remarks.
Learn from Lei Feng's example and temper the quality to clear the spring.
Bayong Beach Dares to Play with Waves and Visits Rivers and Mountains by Xin 'an River.
How do teenagers know the taste of sorrow, three years of cold and summer practice full.
Although I sighed that the Cultural Revolution hindered my studies, I realized my dream.
The vicissitudes of life are in the midst of frost and Hua Ying, and Yi Yang and Yan Nian encourage each other.
Newspaper News Photo
Lu Tian Qiu Jing
Lu Tian Qiu Jing can be circled, orange yellow green red oil painting spots.
The tea mountain is dense and green like seal script, and the lake is light and blue like smoke.
Pilgrim prays for good fortune, and the great immortal gives peace.
The source of the mountain village is far away, please take the time to play.
Qin Tan Villagers Youyuan Zhou Village Great Wall
Qin Tan is deeply embedded in the south mountain depression, with clear sound curling up or not.
Why is there a flat painting around the garden? The Great Wall suddenly peaks.
Dragon Boat Festival Temple Fair Noises Wang Zhai
Tourists are rushing to where, farming delicacies are delicious.
"Wang Zhai Liu Wei" moved his index finger and "Pastoral Eight Wonders" sighed at the spectacle.
set up a hundred tables of peace banquets to celebrate the harvest year of host and guest.
Although the Dragon Boat Festival is a small section, it has fallen out with Wang Zhai and has a near carnival. (North Mountain Woodcutter)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31